检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1 T315I + clones in TKI-resistant CML.

Mathias Schneeweiss-Gleixner,Konstantin Byrgazov,Gabriele Stefanzl,Daniela Berger,Gregor Eisenwort,Chantal Blanche Lucini,Susanne Herndlhofer,Sandra Preuner,Klara Obrova,Petra Pusic,Nadine Witzeneder,Georg Greiner,Gregor Hoermann,Wolfgang R Sperr,Thomas Lion,Michael Deininger,Peter Valent,Karoline V Gleixner

EBioMedicine（2019）

引用 15|浏览79
暂无评分
摘要
This project was supported by the Austrian Science Funds (FWF) projects F4701-B20, F4704-B20 and P30625.
更多
查看译文
关键词
CML,BCR-ABL1 mutations,TKI resistance,Hydroxyurea,CDK4/CDK6 – Palbociclib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要